Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations

Keyphrases

• Liver Transplant Recipients 100%
• Practice Review 100%
• Cardiac Disease 100%
• Practice-based 100%
• Interdisciplinary Practice 100%
• Liver Transplantation 50%
• Epidemiology 25%
• Metabolic Syndrome 25%
• Heart Failure 25%
• Risk Assessment 25%
• High-risk Population 25%
• Coronary Artery Disease 25%
• Expert Panel 25%
• Arrhythmia 25%
• Cardiometabolic Risk 25%
• Nonalcoholic Steatohepatitis 25%
• Risk Mitigation 25%
• Knowledge Gaps 25%
• Most Common Cause 25%
• Advanced Age 25%
• Diabetes Medications 25%
• Valvular Heart Disease 25%
• Cardioprotective Potential 25%
• Multidisciplinary Management 25%
• Sodium-glucose Transporter 2 Inhibitors 25%
• Clinical Outcomes 25%
• Disease Burden 25%

Medicine and Dentistry

• Heart Disease 100%
• Liver Graft 100%
• Liver Transplantation 50%
• Cohort Effect 25%
• Diabetes 25%
• High Risk Population 25%
• Valvular Heart Disease 25%
• Metabolic Syndrome 25%
• Ischemic Heart Disease 25%
• Cardiac Dysrhythmia 25%
• Nonalcoholic Fatty Liver 25%
• Disease Burden 25%
• Congestive Heart Failure 25%
• Sodium Glucose Cotransporter 2 25%
• Cardiometabolic Risk 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Disease 100%
• Metabolic Syndrome X 25%
• Heart Arrhythmia 25%
• Nonalcoholic Fatty Liver 25%
• Congestive Heart Failure 25%
• Sodium Glucose Cotransporter 2 25%
• Ischemic Heart Disease 25%
• Valvular Heart Disease 25%
• Diseases 25%